| 标题 |
Phase 3,Randomized, Double-Blind, Placebo-Controlled ENGOT-0v43/GOG-3036/KEYLYNK-001 Study of 1L Chemotherapy + Pembrolizumab ThenMaintenance Pembrolizumab ± Olaparib for Advanced BRCA-Nonmutated Epithelial Ovarian Cancer: Analysis by Myriad HRD Status
|
| 网址 |
求助人暂未提供
|
| DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
| 其它 | 作者D.Cibula, K.Mcntyre, E.Van Nieuwenhuysen, et al |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)